VVOS
Price:
$2.62
Market Cap:
$8.91M
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands R...[Read more]
Industry
Medical - Devices
IPO Date
2020-12-11
Stock Exchange
NASDAQ
Ticker
VVOS
According to Vivos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.38. This represents a change of -56.93% compared to the average of -0.88 of the last 4 quarters.
The mean historical PE Ratio of Vivos Therapeutics, Inc. over the last ten years is -7.21. The current -0.38 PE Ratio has changed 427.23% with respect to the historical average. Over the past ten years (40 quarters), VVOS's PE Ratio was at its highest in in the March 2023 quarter at 0.44. The PE Ratio was at its lowest in in the June 2020 quarter at -19.85.
Average
-7.21
Median
-7.25
Minimum
-15.01
Maximum
-0.41
Discovering the peaks and valleys of Vivos Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 173.54%
Maximum Annual PE Ratio = -0.41
Minimum Annual Increase = -82.66%
Minimum Annual PE Ratio = -15.01
Year | PE Ratio | Change |
---|---|---|
2023 | -1.12 | 173.54% |
2022 | -0.41 | -82.66% |
2021 | -2.35 | -80.70% |
2020 | -12.20 | -18.76% |
2019 | -15.01 | 23.54% |
The current PE Ratio of Vivos Therapeutics, Inc. (VVOS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.29
5-year avg
-6.22
10-year avg
-7.21
Vivos Therapeutics, Inc.’s PE Ratio is less than Bone Biologics Corporation (-0.27), less than Tivic Health Systems, Inc. (-0.19), less than Bluejay Diagnostics, Inc. (-0.01), greater than Rapid Micro Biosystems, Inc. (-0.72), greater than NanoVibronix, Inc. (-0.59), less than Talis Biomedical Corporation (-0.06), less than Nuwellis, Inc. (-0.02), less than Heart Test Laboratories, Inc. (-0.29),
Company | PE Ratio | Market cap |
---|---|---|
-0.27 | $2.14M | |
-0.19 | $2.03M | |
-0.01 | $935.33K | |
-0.72 | $35.83M | |
-0.59 | $1.65M | |
-0.06 | $2.83M | |
-0.02 | $2.02M | |
-0.29 | $2.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vivos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vivos Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Vivos Therapeutics, Inc. (VVOS)?
What is the highest PE Ratio for Vivos Therapeutics, Inc. (VVOS)?
What is the 3-year average PE Ratio for Vivos Therapeutics, Inc. (VVOS)?
What is the 5-year average PE Ratio for Vivos Therapeutics, Inc. (VVOS)?
How does the current PE Ratio for Vivos Therapeutics, Inc. (VVOS) compare to its historical average?